ACHV vs REGN: Which Stock is Better?

Side-by-side comparison of Achieve Life Sciences Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ACHV

Achieve Life Sciences Inc

$5.49

REGN

Regeneron Pharmaceuticals Inc

$733.78

Key Metrics Comparison

MetricACHVREGNWinner
Market Cap$310.35M$77.69BREGN
P/E RatioN/A17.57REGN
EPS (TTM)$N/A$41.71REGN
Revenue Growth0.0%0.0%REGN
Gross Margin0.0%45.8%REGN

Analyze ACHV

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ACHV or REGN a better investment?

Comparing ACHV and REGN: Achieve Life Sciences Inc has a market cap of $310.35M while Regeneron Pharmaceuticals Inc has $77.69B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ACHV and REGN?

ACHV (Achieve Life Sciences Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ACHV or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ACHV or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for ACHV.

Which company is more profitable: ACHV or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 45.8% compared to 0.0% for ACHV.

Which is the larger company: ACHV or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.69B compared to $310.35M for ACHV.

Should I buy ACHV or REGN in 2026?

Both ACHV and REGN have investment merit. ACHV trades at $5.49 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ACHV and REGN stock?

Key differences: Market Cap ($310.35M vs $77.69B), P/E Ratio (N/A vs 17.6x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 45.8%).

Popular Stock Comparisons